• Company
• Therapeutic device 'improves OS for lung cancer patients'
• by Son, Hyung Min Oct 21, 2024 05:48am

• Company
• Oxlumo receives orphan drug designation in Korea
• by Eo, Yun-Ho Oct 21, 2024 05:48am

• Company
• RNAi therapeutic 'Givlaari' receives the ODD in KOR
• by Eo, Yun-Ho Oct 21, 2024 05:48am

• Company
• Bladder cancer drug Balversa offers new treatment option
• by Whang, byung-woo Oct 18, 2024 05:49am

• Company
• 'Vorasidenib' receives Orphan Drug Designation in KOR
• by Eo, Yun-Ho Oct 18, 2024 05:49am

• Company
• Will blockbuster contraception Mercilon find a new provider?
• by Nho, Byung Chul Oct 18, 2024 05:49am

• Company
• oHCM drug Camzyos's last hurdle to reimb remains high
• by Eo, Yun-Ho Oct 15, 2024 05:50am

• Company
• “Market for veterinary drugs expected to grow rapidly”
• by Son, Hyung Min Oct 15, 2024 05:50am

• Company
• Dong-A ST’s biosimilar first enters the U.S. market
• by Chon, Seung-Hyun Oct 14, 2024 05:49am

• Company
• ERT demonstrates effectiveness in treating Fabry disease
• by Whang, byung-woo Oct 11, 2024 06:25am